Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135986) titled 'Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Sanofi
Condition:
Meningococcal Infection
Healthy Volunteers
Intervention:
Biological: MenACYW conjugate vaccine
Biological: MenAC conjugate vaccine
Recruitment Status: Not recruiting
Phase: Phase 3
Date of Fi...